News
The company will resume the Phase II trial, initially at a lower dose and with a new immunomodulatory regimen.
Steroids May Obscure Predictive Power of Circulating Biomarkers in Lung Cancer Patients, Study Finds
A recent paper has shed more light on how corticosteroids frequently prescribed to lung cancer patients could inhibit the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback